This symposium will assist clinicians in both learning and developing programmatic tools for describing and documenting behavior that occurs as a result of neuroanatomical changes post- brain injury. The ability to effectively treat Brain-Injury Related Behaviors (BIRBs) has limited documentation in the acute phase of recovery (Kretzmer et. al, 2022). Our goal will be to review on-going successful neurobehavioral treatments which include neuro-pharmacological interventions and evidence-based behavior management strategies based in the science of Applied Behavior Analysis (ABA). The group will develop a roadmap to help providers in inpatient rehabilitation facilities develop staff dedicated to behavior management in the care of patients with brain injury. We will outline the adoption of ABA and licensed ABA professionals into the clinical team, the benefits of doing so, and how to overcome potential systematic barriers in place.

This symposium will assist clinicians in both learning and developing programmatic tools for describing and documenting behavior that occurs as a result of neuroanatomical changes post- brain injury. The ability to effectively treat Brain-Injury Related Behaviors (BIRBs) has limited documentation in the acute phase of recovery (Kretzmer et. al, 2022). Our goal will be to review on-going successful neurobehavioral treatments which include neuro-pharmacological interventions and evidence-based behavior management strategies based in the science of Applied Behavior Analysis (ABA). The group will develop a roadmap to help providers in inpatient rehabilitation facilities develop staff dedicated to behavior management in the care of patients with brain injury. We will outline the adoption of ABA and licensed ABA professionals into the clinical team, the benefits of doing so, and how to overcome potential systematic barriers in place.